| P50 | author | Anthony Maxwell | Q37380949 |
| P2093 | author name string | Cove ME | |
| | Tingey AP | |
| P2860 | cites work | Site-specific cleavage of DNA by E. coli DNA gyrase | Q41062694 |
| | The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography | Q41064279 |
| | Appendix. II: Alignment of primary sequences of DNA topoisomerases. | Q41315322 |
| | DNA gyrase complex with DNA: determinants for site-specific DNA breakage | Q41786070 |
| | Tryptic fragments of the Escherichia coli DNA gyrase A protein. | Q43511755 |
| | Sites of reaction of Escherichia coli DNA gyrase on pBR322 in vivo as revealed by oxolinic acid-induced plasmid linearization | Q43785093 |
| | Cloning of the DNA gyrase genes under tac promoter control: overproduction of the gyrase A and B proteins | Q44689610 |
| | Minimal DNA requirement for topoisomerase II-mediated cleavage in vitro | Q45169409 |
| | The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs. | Q52399144 |
| | The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. | Q54194852 |
| | Mapping the topography of DNA wrapped around gyrase by nucleolytic and chemical probing of complexes of unique DNA sequences. | Q54538652 |
| | Probing the limits of the DNA breakage-reunion domain of the Escherichia coli DNA gyrase A protein. | Q54700296 |
| | The intrinsic ATPase of DNA gyrase | Q55062440 |
| | Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate | Q58318876 |
| | Minimal DNA duplex requirements for topoisomerase I-mediated cleavage in vitro | Q58318881 |
| | The Interaction of Coumarin Antibiotics with Fragments of the DNA Gyrase B Protein†| Q59695045 |
| | Structure of the DNA gyrase-DNA complex as revealed by transient electric dichroism | Q59695104 |
| | The DNA dependence of the ATPase activity of DNA gyrase | Q59695110 |
| | DNA Gyrase: Site-specific Interactions and Transient Double-strand Breakage of DNA | Q64390730 |
| | Slow interaction of 5'-adenylyl-beta,gamma-imidodiphosphate with Escherichia coli DNA gyrase. Evidence for cooperativity in nucleotide binding | Q67847330 |
| | Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA | Q69352938 |
| | Intramolecular and intermolecular DNA ligation mediated by topoisomerase II | Q72109492 |
| | Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors | Q26778475 |
| | The interaction between coumarin drugs and DNA gyrase | Q28256018 |
| | DNA topoisomerases | Q29619953 |
| | DNA gyrase binds to the family of prokaryotic repetitive extragenic palindromic sequences | Q33676488 |
| | A DNA gyrase-binding site at the center of the bacteriophage Mu genome is required for efficient replicative transposition | Q33887701 |
| | Crystal structure of an N-terminal fragment of the DNA gyrase B protein. | Q34493198 |
| | DNA gyrase: structure and function. | Q34507230 |
| | A novel suicide substrate for DNA topoisomerases and site-specific recombinases | Q34765037 |
| | Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme | Q35059616 |
| | Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity | Q35059655 |
| | The molecular basis of quinolone action | Q35238284 |
| | Contacts between DNA gyrase and its binding site on DNA: features of symmetry and asymmetry revealed by protection from nucleases | Q35319882 |
| | Site-specific interaction of DNA gyrase with DNA | Q35397299 |
| | The binding of gyrase to DNA: analysis by retention by nitrocellulose filters | Q35719264 |
| | The partition locus of plasmid pSC101 is a specific binding site for DNA gyrase | Q36064962 |
| | Conversion of DNA gyrase into a conventional type II topoisomerase | Q37039334 |
| | Structure-activity relationships in DNA gyrase inhibitors | Q37902823 |
| | Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events | Q38323769 |
| | New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site | Q38331894 |
| | Inhibitors of DNA gyrase | Q38333670 |
| | Nuclease protection by Drosophila DNA topoisomerase II. Enzyme/DNA contacts at the strong topoisomerase II cleavage sites. | Q38342686 |
| | DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex | Q38356745 |
| | In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites | Q39718939 |
| | Effect of pyrimido[1,6-a]benzimidazoles, quinolones, and Ca2+ on the DNA gyrase-mediated cleavage reaction | Q39778933 |
| | Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting | Q40399549 |
| | Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism | Q40476934 |
| | The C-terminal domain of the Escherichia coli DNA gyrase A subunit is a DNA-binding protein | Q40532451 |
| | The cleavage of DNA at phosphorothioate internucleotidic linkages by DNA gyrase | Q40533036 |
| | DNA topoisomerases: essential enzymes and lethal targets | Q40678987 |
| | DNA gyrase can supercoil DNA circles as small as 174 base pairs | Q40818144 |
| | DNA gyrase as a drug target | Q40902870 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | quinolones | Q426549 |
| P304 | page(s) | 2716-2722 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs | |
| P478 | volume | 25 | |